Sclerotherapy in oral cavity hemangioma with glucose and ethanolamine oleate. Case reports
DOI:
https://doi.org/10.5935/2525-5711.20190011Keywords:
Hemangioma capillary, Sclerotherapy, Sclerosing solutions, Ethanolamine, GlucoseAbstract
Introduction: the hemangioma is a vascular lesion of uncertain etiology. It is most fre- quently observed in the head and neck region (50% of the cases). In the oral cavity, com- monly affect the lower lip, tongue, jugal mucosa and palate. There are several therapeutic modalities to treat hemangiomas, among them; sclerotherapy stands out, since it represents a simple, comfortable, effective and low-cost method of treatment. Objective: compare the treatment between two sclerosing agents: the ethanolamine oleate 5% and glucose solution 50%. Side effects and period of treatment was also analyzed and illustrated with three clinical cases. Material and methods: three cases presenting diascopy blanching lesions, and vascular injury, were aspirated being collected bloody content, confirming the diagnosis of vascular injury, and establishing a clinical diagnosis of hemangioma. Infiltration anesthesia was applied at a distance, and slow implementation of sclerosing agents was injected, intralesionally. An interval of seven days between each application was maintained. Patients were asked about possible occurrence of side effects: burning, pain, swelling the region. Results: both sclerosing agents used in this study are efficient, easy to perform, with market availability and reduced cost. Conclusion: regarding the duration of the treatment, no significant difference between the sclerosing agents was observed, because both needed a few applications for the complete resolution of the lesions, no recurrence was observed and early side effects were pain, swelling, redness and burning.
References
Rashmi G, Dilip SS, Siddhartha A, Wasim K. A review of hemangiomas of the oral cavity. Unique J Med Dent Sci. 2015; 3(4):4-6.
Johann AC, Aguiar MC, do Carmo MA, Gomez RS, Castro WH, Mesquita RA. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100(5):579-84.
Bonan PRF, Miranda LDP, Mendes DC, Paula AMBD, Pego SPB, Martelli-Júnior H. Effectiveness of low flow vascular lesions sclerosis with monoetanolamine: report of six cases. Med Oral Patol Oral Cir Bucal. 2007; 12(7):524-7.
da Silva WB, Ribeiro AL, de Menezes SA, de Jesus VPJ, de Melo Jr AS. Oral capillary hemangioma: a clinical protocol of diagnosis and treatment in adults. Oral Maxillofac Surg. 2014; 18(4):431-7.
Cruz FLG, Carvalho RF, Carvalho MF, Sales LAR, Devito KL. Differential diagnosis of hemangioma by diascopy. Porto Alegre: RGO - Rev Gaúcha Odontol. 2011; 59(1):125-9.
Novoa M, Baselga E, Beltran S, Giraldo L, Shahbaz A, Pardo- -Hernandez H, et al. Interventions for infantile haemangiomas of the skin. Cochrane Database Syst Rev. 2018; 4:Cd006545.
Correa PH, Nunes LC, Johann AC, Aguiar MC, Gomez RS, Mesquita RA. Prevalence of oral hemangioma, vascular malformation and varix in a Brazilian population. Braz Oral Res. 2007; 21(1):40-5.
Queiroz SIML, de Assis GM, Silvestre VD, Germano AR, da Silva JSP. Treatment of oral hemangioma with sclerotherapy: case report. J Vasc Bras. 2014; 13(3):249-53.
Moyakine AV, Herwegen B, van der Vleuten CJM. Use of the hemangioma severity Scale to facilitate treatment decisions for infantile hemangiomas. J Am Acad Dermatol. 2017; 77(5):868- 73.
Jaeger F, Alvarenga RL, Galizes BF, Girardi GP, Alvarenga GL, Leal RM. Escleroterapia com oleato de etanolamina a 5% em hemangioma oral: relato de caso clínico. Rev Port Estomatol Med Dent Cir Maxilofac. 2013; 54(2):91-4.
Fong CJ, Garzon MC, Hoi JW, Kim HK, Lauren CT, Morel K, Geller L, et al. Assessment of infantile hemangiomas using a handheld wireless diffuse optical spectroscopic device. Ped Dermatol. 2017; 34(4):386-91.
Li DN, Gold MH , Sun Z, Tang AR, Wang HB, Kang LS. Treatment of infantile hemangioma with optimal pulse technology. J Cosm Laser Ther. 2010; 12:145-50.
Cruz-Filho M, Maia CC, Abrahão S, Silva JCCB, Gomes PO, Soufen MA, et al. Effectiveness of low flow vascular lesions sclerosis with monoetanolamine: Report of six cases. Acta Cir Bras. 2002; 17(5):317-26.
Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol. 2010; 27(4):391-9.
Figueiredo M, Figueiredo MF. Survey on liquid sclerotherapy of lower limb varicose veins. J Vasc Bras. 2013; 12(1):10-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 1969 Marcio Gonçalves da-Silva, Michelle Palmieri, Henrique Camargo Bauer, Anna C R T Horliana, Waldyr Antonio Jorge, Renata Matalon Negreiros
This work is licensed under a Creative Commons Attribution 4.0 International License.
